Efficacy and Safety of EzetimiBe/Rosuvastatin in Diabetic Dislipidemia With Hypertriglyceridaemia

NCT04700436 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

146

Enrollment

OTHER

Sponsor class

Conditions

Endocrine System Diseases
Nutritional and Metabolic Diseases
Diabetes Mellitus, Type 2
Dyslipidemias

Interventions

DRUG: Rosuzet tablet 10/5 mg (Ezetimibe 10 mg/Rosuvastatin 5 mg)
DRUG: Suvast tablet 10 mg (Rosuvastatin 10 mg)

Sponsor

Seoul National University Hospital

Collaborators

[object Object]